Xuebijing injection improves the respiratory function in rabbits with oleic Acid‑Induced acute lung injury by inhibiting IL‑6 expression and promoting IL‑10 expression at the protein and mRNA levels

Experimental and Therapeutic Medicine

Volumn 8, Issue 5, 2014, Pages 1593-1598

  Wang, Yuxia ^a   Ji, Mingli ^a   Wang, Lei ^b   Chen, Liping ^a   Li, Jing ^b  

^a XINXIANG MEDICAL UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF XINXIANG MEDICAL UNIVERSITY   (China)

Author keywords

Acute lung injury; Interleukin 10; Interleukin 6; Myeloperoxidase; Oleic acid; Xuebijing injection

Indexed keywords

CHINESE DRUG; INTERLEUKIN 10; INTERLEUKIN 6; MESSENGER RNA; MYELOPEROXIDASE; OLEIC ACID; UNCLASSIFIED DRUG; XUEBIJING INJECTION;

ACUTE LUNG INJURY; ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLORIMETRY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOHISTOCHEMISTRY; MULTIPLE ORGAN FAILURE; NONHUMAN; OPTICAL DENSITY; PROTEIN EXPRESSION; RABBIT; RESPIRATORY FAILURE; RESPIRATORY FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION;

EID: 84907816887     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2014.1949     Document Type: Article

References (27)

1. Liu W and Jin FG: New progress of acute lung injury and acute respiratory distress syndrome. Chin J Lung Dis (Electronic Edition) 1 : 61-64, 2013 (In Chinese).
2. Chang HM, Ji ML, Song XR, et al: Effect of inflammatory cell adhesion molecules-1 on acute lung injury in infant rats following meconium aspiration. Shi Yong Er Ke Lin Chuang Za Zhi 27: 1835-1836, 2012 (In Chinese).
3. Saraiva M and O'Garra A: The regulation of IL-10 production by immune cells. Nat Rev Immunol 10: 170-181, 2010.
4. Rittirsch D, Flierl MA and Ward PA: Harmful molecular mechanisms in sepsis. Nat Rev Immunol 8: 776-787, 2008.
5. Porter JC and Hall A: Epithelial ICAM-1 and ICAM-2 regulate the egression of human T cells across the bronchial epithelium. FASEB J 23: 492-502, 2009.
6. Grommes J and Soehnlein O: Contribution of neutrophils to acute lung injury. Mol Med 17: 293-307, 2011.
7. Orlikowsky T, Wang ZQ, Dudhane A, et al: Two distinct pathways of human macrophage differentiation are mediated by interferon-gamma and interleukin-10. Immunology 91: 104-108, 1997.
8. Kylänpää L, Rakonczay Z Jr and O'Reilly DA: The clinical course of acute pancreatitis and the inflammatory mediators that drive it. Int J Inflam 2012: 360685, 2012.
9. Favarin DC, de Oliveira JR, de Oliveira CJ and Rogerio Ade P: Potential effects of medicinal plants and secondary metabolites on acute lung injury. Biomed Res Int 2013: 576479, 2013.
10. Welty-Wolf KE, Carraway MS, Ortel TL and Piantadosi CA: Coagulation and inflammation in acute lung injury. Thromb Haemost 88: 17-25, 2002.
11. Tanaka T and Kishimoto T: Targeting interleukin-6: all the way to treat autoimmune and inflammatory diseases. Int J Biol Sci 8: 1227-1236, 2012.
12. Frisdal E, Lesnik P, Olivier M, et al: Interleukin-6 protects human macrophages from cellular cholesterol accumulation and attenuates the proinflammatory response. J Biol Chem 286: 30926-30936, 2011.
13. Steiner MK, Syrkina OL, Kolliputi N, et al: Interleukin-6 overexpression induces pulmonary hypertension. Circ Res 104: 236-244, 2009.
14. Pedroza M, Schneider DJ, Karmouty-Quintana H, et al: Interleukin-6 contributes to inflammation and remodeling in a model of adenosine mediated lung injury. PLoS One 6: e22667, 2011.
15. Seki T, Kumagai T, Kwansa-Bentum B, et al: Interleukin-4 (IL-4) and IL-13 suppress excessive neutrophil infiltration and hepatocyte damage during acute murine schistosomiasis japonica. Infect Immun 80: 159-168, 2012.
16. Hedrich CM and Bream JH: Cell type-specific regulation of IL-10 expression in inflammation and disease. Immunol Res 47: 185-206, 2010.
17. + Tregs resolve experimental lung injury in mice and are present in humans with acute lung injury. J Clin Invest 119: 2898-2913, 2009.
18. Poe SL, Arora M, Oriss TB, et al: STAT1-regulated lung MDSC-like cells produce IL-10 and efferocytose apoptotic neutrophils with relevance in resolution of bacterial pneumonia. Mucosal Immunol 6: 189-199, 2013.
19. Jiang M, Zhou M, Han Y, et al: Identification of NF-κB inhibitors in Xuebijing injection for sepsis treatment based on bioactivity-integrated UPLC-Q/TOF. J Ethnopharmacol 147: 426-433, 2013.
20. He XD, Wang Y, Wu Q, et al: Xuebijing protects rats from sepsis challenged with Acinetobacter baumannii by promoting annexin A1 expression and inhibiting proinflammatory cytokines secretion. Evid Based Complement Alternat Med 2013: 804940, 2013.
21. Song XR: Regulation of breathing exercises and experimental acute respiratory failure. In: Medical Function Experiment. Chang QZ (ed). 2nd edition. People's Medical Publishing House, Beijing, pp124-125, 2007.
22. Yu P, Bu H, Wang H, et al: Comparative study on image analysis and manual counting of immunohistochemistry. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi 20: 288-290, 2003 (In Chinese).
23. Jiang H, Meng F, Li W, et al: Splenectomy ameliorates acute multiple organ damage induced by liver warm ischemia reperfusion in rats. Surgery 141: 32-40, 2007.
24. Smith JA: Neutrophils, host defense, and inflammation: a double-edged sword. J Leukoc Biol 56: 672-686, 1994.
25. Li YP, Qiao YJ, Wu ZX, et al: Effects of Xuebijing injection on protein C and tumor necrosis factor-alpha mRNA in rats with sepsis. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 19: 488-491, 2007 (In Chinese).
26. Qi F, Liang ZX, She DY, et al: A clinical study on the effects and mechanism of xuebijing injection in severe pneumonia patients. J Tradit Chin Med 31: 46-49, 2011.
27. Zhang P, Cao SH, Cui KL, et al: The influences of Xuebijing on the expression of human leukocyte antigen-DR on monocytes in patients with multiple organ dysfunction syndrome. Zhong Guo Zhong Xi Yi Jie He Za Zhi 9: 21-23, 2002 (In Chinese).